A CD248-specific antibody-drug conjugate (IgG78-DM1) was generated that could bind specifically with and kill CD248-positive hepatic stellate cells in vitro, could alleviate liver fibrosis in vivo, and had a good safety profile. This evidence concerns the gene CD248 and Hepatic fibrosis.